ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2018 American Transplant Congress

    Clinically Relevant Variation of Donor-Derived Cell-Free DNA during Longitudinal Surveillance of Renal Allografts

    M. Narayanan,1 T. Alhamad,2 D. Hiller,3 J. Yee,3 R. Woodward,3 J. Bromberg.4

    1Texas A&M Health Science Center, Temple, TX; 2Washington University School of Medicine, St. Louis, MO; 3CareDx, Brisbane, CA; 4University of Maryland School of Medicine, Baltimore, MD.

    Purpose: Donor-derived cell-free DNA (dd-cfDNA) levels >1% are associated with active rejection in renal transplant recipients. This report defines the clinically relevant variation of dd-cfDNA…
  • 2018 American Transplant Congress

    Comparison of Induction and Maintenance Immunosuppression Regimens in Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Registry

    S. Nagai,1 M. Rizzari,1 Y. Muszkat,2 K. Collins,1 A. Yoshida,1 S-.M. Jafri,2 M. Abouljoud.1

    1Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; 2Gastroenterology, Henry Ford Hospital, Detroit, MI.

    Aim: Induction and maintenance immunosuppression regimens in intestinal transplant widely vary among centers. The aim of this study was to investigate an association between immunosuppression…
  • 2018 American Transplant Congress

    Incidence of Acute Cellular Rejection in Liver Transplant Patients Receiving Direct Acting Antivirals for Hepatitis C Treatment

    D. Bley,1 L. Sagardia,1 R. Ford,2 S. Todd.1

    1Pharmacy, Emory University Hospital, Atlanta, GA; 2School of Medicine, Emory University, Atlanta, GA.

    Direct acting antivirals (DAAs) have been used for the treatment of hepatitis C (HCV) in liver transplant patients since early on after their approval, however…
  • 2018 American Transplant Congress

    Pro-Inflammatory B Cells Predict Progressive Minimal Early Renal Allograft Inflammation Which is Associated with Poor Graft Outcomes

    A. Sharma, A. Cherukuri, D. Chittka, R. Mehta, S. Hariharan, D. Rothstein.

    UPMC, Pittsburgh.

    The clinical significance of minimal tubulointerstitial inflammation (MTI:'t'+'i'scores 0.5-1.5) and Banff Borderline changes (BBC:'t'+'i'scores 2-3) in early renal allograft biopsies is unclear. The rate and…
  • 2018 American Transplant Congress

    DSA with TCMR Identifies High Risk Renal Transplant Recipients That Can Be Predicted by Proinflammatory Transitional B Cells

    D. Chittka, A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.

    Starzl Transplant Inst., Univ. of Pittsburgh, Pittsburgh.

    Post-transplant DSA is strongly associated with poor graft outcomes but has limited predictive value. In this prospective study we aimed to risk-stratify patients with early…
  • 2018 American Transplant Congress

    Isolation and Profiling of miRNAs from Formalin Fixed Paraffin Embedded Endomyocardial Tissues from Human Heart Transplant Recipients

    R. Nog,1,2 C. Gupta,1,2 J. Fallon,1,2 J. Panza,1,2 N. Haque.2

    1Westchester Medical Center, Valhalla, NY; 2New York Medical College, Valhalla, NY.

    Allograft rejection is a common complication post heart transplant (HTx) and can be confirmed by endomyocardial biopsy (EBx) only. There is however an increasing need…
  • 2018 American Transplant Congress

    Comparison of Bortezomib in Addition to Rituximab Based Treatment of Acute Antibody Mediated Rejection in Kidney Transplantation

    A. Mattiazzi,1,2 J. Pagan,1,2 A. Arunachalam,1 I. De la Cruz Alcantara,1 J. Revollo,2 A. Centeno,2 A. Valdes,1,2 G. Guerra.1,2

    1Nephrology & Hypertension, University of Miami, Miami, FL; 2Miami Transplant Institute, Jackson Memorial Hospital, Miami, FL.

    Purpose:The optimal treatment strategy of acute antibody mediated rejection (AMR) in renal allograft recipients remains undefined. The aim of our study was to compare the…
  • 2018 American Transplant Congress

    Magnitude of Pre-Biopsy Decline in Renal Function and Its Association with Allograft Rejection

    S. Voora,1 P. Ahearn,1 M. Tavakol,2 K. Johansen,1,3 E. Ku.1

    1Division of Nephrology, UCSF, San Francisco, CA; 2Department of Surgery, UCSF, San Francisco, CA; 3Department of Epidemiology/Biostatistics, UCSF, San Francisco, CA.

    Introduction: Acute rejection is a significant cause of morbidity, and transplant biopsy remains the gold standard for diagnosing rejection. To our knowledge there have been…
  • 2018 American Transplant Congress

    Metabolic Regulation of Neuropeptides Induces Weight Loss and is Linked to Prolongation of Allograft Survival

    M. Quante,1,2 T. Heinbokel,1 K. Minami,1 Y. Nian,1 A. Elkhal,1 S. Tullius.1

    1Transplant Surgery Research Lab, Brigham and Women's Hospital, Boston, MA; 2Department of General, Visceral and Transplant Surgery, Tuebingen Unversity Hospital, Tuebingen, Germany.

    Obesity has become a common comorbidity among transplant recipients that is linked to inferior transplant outcome through far-reaching effects on metabolism, inflammation and immunity. Increasingly,…
  • 2018 American Transplant Congress

    Optimal Anti-Thymocyte Globulin Dose for Induction Immunosuppression in Kidney Transplantation

    A. Mitrokhin, J. Goldman, B. Trivedi, V. Vidyasagar, N. Vadivel, M. Hart.

    Organ Transplant Program, Swedish Medical Center, Seattle, WA.

    Anti-thymocyte globulin (ATG) is used as induction immunosuppression in kidney transplantation to prevent allograft rejection. ATG causes dose-dependent lymphocyte depletion, yet optimal dose is unknown.…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences